Concerns and needs for research in herbal supplement pharmacotherapy and safety

Journal of Herbal Pharmacotherapy

Volumn 1, Issue 2, 2001, Pages 3-23

  Kroll, D J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Adverse drug interactions; Drug metabolism; Drug safety; Herbs

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE; BETA 1 ADRENERGIC RECEPTOR; CAMPTOTHECIN; CHINESE DRUG; CHLORDIAZEPOXIDE; CHOLESTEROL; CODEINE; COMPACTIN; DIURETIC AGENT; DNA TOPOISOMERASE; GINSENG EXTRACT; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; INDOMETACIN; MORPHINE; NATURAL PRODUCT; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PLACEBO; SILDENAFIL; SNAKE VENOM; TOPOTECAN; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROL SYSTEM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG CHOICE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG INFORMATION; DRUG LEGISLATION; DRUG MARKETING; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; DRUG USE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; MEDICAL EDUCATION; PAPAVER SOMNIFERUM; PHARMACEUTICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; TRAINING; UNITED STATES;

EID: 0035065550     PISSN: 15228940     EISSN: None     Source Type: Journal    
DOI: 10.1300/J157v01n02_02     Document Type: Article

References (77)

1. The societal value of pharmaceuticals. Balancing industrial and healthcare policy
2. Pharmaceutical research and development
3. Lovastatin and simvastatin-inhibitors of HMG CoA reductase and cholesterol biosynthesis
4. Camptothecin and taxol: From discovery to clinic
5. Medicinal plants and Alzheimer's disease: From ethnobotany to phytotherapy
6. Plant hallucinogens: Springboards for psychotherapeutic drug discovery
7. Friedrich Wilhelm Adam Serturner-on the 150th anniversary of the death of the discoverer of morphine
8. Medication use in an imperfect world: Drug misadventuring as an issue of public policy
9. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
10. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
11. Points to consider about prescription drug prices: An overview of federal policy and pricing studies
12. The other drug lords
13. Modernizing the FDA: An incremental revolution
14. Molecular mechanisms of genetic polymorphisms of drug metabolism
15. One-third of nation's adults use herbal remedies: Market estimated at $3.24 billion
16. Unconventional medicine in the United States: Prevalence, costs and patterns of use
17. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia
18. St. John's wort for depression-an overview and meta-analysis of randomized clinical trials
19. The antiatherosclerotic effect of Allium sativum
20. Health risks of herbal remedies
21. Pharmacokinetic evaluation of herbal remedies: Basic introduction, applicability, current status, and regulatory needs
22. Safety issues in herbal medicines: Implications for the health professions
23. Herbal medicinals: Selected clinical consideration focusing on known or potential drug-herb interactions
24. Herbal remedies: Adverse effects and drug interactions
25. St. John's wort and antidepressant drug interactions in the elderly
26. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract
27. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng
28. Potential metabolic interaction between St. John's wort and theophylline
29. Panax ginseng pharmacology: A nitric oxide link?
30. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction
31. Herbs as medicines
32. Alternative medicine: The risks of untested and unregulated remedies
33. Identification of prescription drugs in adulterated Chinese herbal medicines
34. Arsenic and mercury intoxication due to Indian ethnic remedies
35. Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone
36. Alopeica and sensory neuropathy from thallium in a Chinese herbal medication
37. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995)
38. Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium
39. What do commercial ginseng preparations contain?
40. Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults
41. Pharmaceutical excipients. Adverse effects associated with ingredients in drug products
42. Danggui (Angelica sinsensis) affects the pharmcodynamics but not the pharmacokinetics of warfarin in rabbits
43. Potentiation of warfarin by dong quai
44. Interactions of warfarin with drugs and food
45. Subarachnoid haemorrhage associated with Ginkgo biloba
46. Dietary phytoestrogens and their role in hormonally dependent disease
47. Eating to beat breast cancer: Potential role for soy supplements
48. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast
49. Estrogenic effects of genistein on the growth of estrogen receptor postive human breast cancer (MCF-7) cells in vitro and in vivo
50. Untersuchungen zum Freisetzungverhalten und zer Bioaequivalence von Silymarin-praeparaten [The solubility and bioequivalence of silymarin preparations]
51. Evolution of the cytochrome P450 superfamily: Sequence alignments and pharmacogenetics
52. P450 superfamily: Update on new sequences, gene mapping, accession numbers, and nomeclature
53. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
54. Drug interactions with grapefruit juice
55. Indinavir concentrations and St. John's wort
56. Acute heart transplant rejection due to Saint John's wort
57. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort extract (Hypericum perforatum)
58. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
59. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers
60. Alternative medicine-the case of herbal remedies
61. Herbal instruction in United States pharmacy schools
62. Complementary and alternative medicine education in United States pharmacy schools
63. Courses involving complementary and alternative medicine at U.S. medical schools
64. 'You people': Intolerance and alternative medicine
65. Natural medicine
66. Why patients use alternative medicine: Results of a national study
67. A review of 12 commonly used medicinal herbs
68. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial
69. Therapeutic actions of garlic constituents
70. Postmarketing surveillance and adverse drug reactions: Current perspectives and future needs